News
Press Releases
DiNAQOR AG Announces Research Collaboration and License Agreement with UCL to Investigate Gene Therapies for Heart Failure
January 13, 2020
DiNAQOR today announced a research collaboration and exclusive license agreement with UCL to develop novel gene therapies for the treatment of monogenic cardiomyopathies
Lonza and DiNAQOR AG Announce Strategic Collaboration to Advance Gene Therapy Programs for Patients with Monogenic Cardiomyopathies
November 26, 2019
Strategic collaboration to focus on DiNAQOR’s adeno-associated virus gene therapy production system Companies to partner on gene therapy process and analytical development for preclinical, clinical